FGA (fibrinogen alpha chain)43 and FGB (fibrinogen beta chain)44 levels are correlated with disease severity in patients with cardiovascular disease, but these genes might provide new targets for the development of drugs to treat T1DM. This evidence concerns the gene FGA and type 1 diabetes mellitus.